LivaNova Reports First Quarter 2021 Results

Go back to LivaNova Reports First Quarter 2021 Results

Livanova (LIVN) PT Raised to $99 at Piper Sandler Following Earnings

April 28, 2021 1:33 PM EDT

Piper Sandler analyst Adam Maeder raised the price target on Livanova (NASDAQ: LIVN) to $99.00 (from $92.00) while maintaining a Overweight rating.

... More

LivaNova plc (LIVN) Tops Q1 EPS by 21c, Revenues Beat; Offers FY21 EPS Mid-Point Guidance Above Consensus

April 28, 2021 5:43 AM EDT

LivaNova plc (NASDAQ: LIVN) reported Q1 EPS of $0.36, $0.21 better than the analyst estimate of $0.15. Revenue for the quarter came in at $247.6 million versus the consensus estimate of $232.3 million.

Epilepsy sales growth in the quarter reflects improving market dynamics, especially in the United... More